Literature DB >> 16753158

Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy.

Beata E Seeber1, Mary D Sammel, Wensheng Guo, Lan Zhou, Amy Hummel, Kurt T Barnhart.   

Abstract

OBJECTIVE: To validate recently characterized curves of hCG rise and fall that are seen in viable and nonviable pregnancies in a population of women who have pregnancies of unknown location.
DESIGN: Historical cohort study.
SETTING: University hospital. PATIENT(S): One thousand two hundred forty-nine women with symptomatic early pregnancies. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Comparison of observed hCG values to predicted hCG values; time to diagnosis of ectopic pregnancy; accuracy of diagnosis. RESULT(S): Of the 1,249 patients included in this study, 196 had ectopic pregnancy (EP); 261, intrauterine pregnancy (IUP); and 792, spontaneous abortion (SAB). By determining the rate of change in hCG values from two consecutive visits and comparing them with a minimal rise of 35% in 2 days (the bound that is defined by the 99.9% confidence interval [CI] for the rise of hCG in an IUP) or a minimal fall of 21%-35% (the bound that is defined by the 90% CI for the fall of hCG in an SAB), we were able to make the diagnosis of EP an average of 2.5 days sooner than by standard clinical practice. Only 12% of patients had an EP go undiagnosed by using these rules, because the curve of rise or fall of their hCG mimicked that of a non-EP gestation. CONCLUSION(S): Recently redefined curves of rise and fall in hCG for IUP and SAB are valid for clinical use on the basis of our application to this large cohort of patients. Using them can shorten the time needed to make the diagnosis of EP. Use of a more conservative cutoff for minimal rise in hCG, one as slow as 35% over 2 days, to characterize a potentially viable gestation would minimize potential interruption of a desired pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16753158     DOI: 10.1016/j.fertnstert.2005.12.056

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  Prediction of outcome in women with symptomatic first-trimester pregnancy: focus on intrauterine rather than ectopic gestation.

Authors:  Bruno C Casanova; Mary D Sammel; Jesse Chittams; Kelly Timbers; Jennifer L Kulp; Kurt T Barnhart
Journal:  J Womens Health (Larchmt)       Date:  2009-02       Impact factor: 2.681

2.  Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary.

Authors:  J Zee; M D Sammel; K Chung; P Takacs; T Bourne; K T Barnhart
Journal:  Hum Reprod       Date:  2013-12-18       Impact factor: 6.918

3.  Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules.

Authors:  Christopher B Morse; Mary D Sammel; Alka Shaunik; Lynne Allen-Taylor; Nicole L Oberfoell; Peter Takacs; Karine Chung; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

4.  The association of maternal factors with delayed implantation and the initial rise of urinary human chorionic gonadotrophin.

Authors:  A M Z Jukic; C R Weinberg; D D Baird; A J Wilcox
Journal:  Hum Reprod       Date:  2011-02-02       Impact factor: 6.918

5.  Validation of a clinical risk scoring system, based solely on clinical presentation, for the management of pregnancy of unknown location.

Authors:  Kurt T Barnhart; Mary D Sammel; Peter Takacs; Karine Chung; Christopher B Morse; Katherine O'Flynn O'Brien; Lynne Allen-Taylor; Alka Shaunik
Journal:  Fertil Steril       Date:  2012-10-03       Impact factor: 7.329

6.  Temporal refinement does not affect predicted human chorionic gonadotropin rise in early pregnancy.

Authors:  Andrew R Fisher; Mary D Sammel; Suneeta Senapati; Ashley Singer; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2016-04-07       Impact factor: 7.329

7.  Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation.

Authors:  Kurt T Barnhart; Wensheng Guo; Mark S Cary; Christopher B Morse; Karine Chung; Peter Takacs; Suneeta Senapati; Mary D Sammel
Journal:  Obstet Gynecol       Date:  2016-09       Impact factor: 7.661

8.  Prediction of location of a symptomatic early gestation based solely on clinical presentation.

Authors:  Kurt T Barnhart; Bruno Casanova; Mary D Sammel; Kelly Timbers; Karine Chung; J L Kulp
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

9.  Misdiagnosis and delayed diagnosis for ectopic and heterotopic pregnancies after in vitro fertilization and embryo transfer.

Authors:  Lin-Lin Wang; Xin Chen; De-Sheng Ye; Yu-Dong Liu; Yu-Xia He; Wei Guo; Shi-Ling Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

10.  Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial.

Authors:  Kurt T Barnhart; Mary D Sammel; Mary Stephenson; Jared Robins; Karl R Hansen; Wahid A Youssef; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2018-09-20       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.